A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Study Identifier
MA-ACZ1001
CT.gov Identifier
NCT01231334
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dermatology - Acne
    • Study Drug
  • Dapsone plus Adapalene
  • Clindamycin/benzoyl peroxide plus Adapalene
    • Phase
    Phase 4
    Sex
    Female
    Age
    18 - 40 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Severe facial acne (acne vulgaris)
    Exclusion Criteria:
    * History of significant anemia or hemolysis * History of enteritis (eg, regional enteritis, ulcerative colitis, pseudomembranous colitis, antibiotic-associated colitis) * History of lupus, rosacea, or seborrheic dermatitis

    Protocol Summary

    A study comparing the topical application of Aczone® plus Differin® versus Duac® plus Differin® in patients with severe facial acne (facial acne vulgaris).

    Study Locations

    Location
    Status
    Location
    Miramar, Florida, United States
    Status
    Not applicable